| Effects of utero-ovarian anastomoses on basal follicle-stimulating hormone level change after uterine artery embolization with tris-acryl gelatin microspheres. | |
| | |
MedLine Citation:
|
PMID: 16778229 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To assess the prevalence of anastomoses between uterine and ovarian arteries on angiography and their impact on changes in basal follicle-stimulating hormone (FSH) level after uterine artery embolization (UAE). MATERIALS AND METHODS: Consecutive premenopausal women who underwent UAE for symptomatic uterine leiomyomata according to a uniform embolization technique with tris-acryl gelatin microspheres at a single institution were included in the study. Basal FSH levels before UAE and 6 months after UAE were compared for patients with and without anastomoses between uterine and ovarian arteries on angiography. RESULTS: Among 124 patients included in the study (mean age, 43.1+/-5.7 years), patent anastomoses between the uterine and ovarian arteries were detected by angiography in 55 patients (44.4%). Overall, 11.3% of 124 patients showed an increase in basal serum FSH level of greater than 20 mIU/mL after UAE. In patients with utero-ovarian anastomoses, 18.2% showed an increase of greater than 20 mIU/mL after UAE, compared with 5.8% of patients without such anastomoses (P=.03). Mean basal FSH increase after UAE in patients with anastomoses was 8.4+/-20.2 mIU/mL, compared with 2.7+/-10.6 mIU/mL in patients without anastomoses (P=.047). Among patients with anastomoses, the 50- to 54-year age group had the highest percentage of patients with an FSH increase greater than 20 mIU/mL (50.0%) after UAE, followed by patients in the 45- to 49-year age group (15.4%). CONCLUSIONS: Angiographically detected anastomoses between the uterine artery and the ovarian artery are not uncommon. UAE in patients with anastomoses is associated with a greater risk of significant increase of basal FSH level than in UAE in patients without anastomoses. The pathophysiologic processes resulting in change of FSH level may be a reflection of diminished ovarian function, but further study is warranted to delineate the precise mechanism. |
| | |
Authors:
|
Hyun S Kim; Jason Tsai; Judy M Lee; Russell Vang; John G Griffith; Edward E Wallach |
Related Documents
:
|
22701539 - External urethral sphincter pressure measurement: an accurate method for the diagnosis ... 18930219 - Does a clinical varicocele influence the relationship between testicular volume by ultr... 2161009 - Color doppler sonography in acute epididymitis and orchitis. 366849 - Medical treatment of the subfertile male. 22771289 - Parkinsonian tremor identification with multiple local field potential feature classifi... 22842299 - Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a... 15742109 - Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopath... 17963519 - Islet cell autoantibodies in african patients with type 1 and type 2 diabetes in dar es... 16489569 - Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascu... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of vascular and interventional radiology : JVIR Volume: 17 ISSN: 1051-0443 ISO Abbreviation: J Vasc Interv Radiol Publication Date: 2006 Jun |
Date Detail:
|
Created Date: 2006-06-16 Completed Date: 2006-11-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9203369 Medline TA: J Vasc Interv Radiol Country: United States |
Other Details:
|
Languages: eng Pagination: 965-71 Citation Subset: IM |
Affiliation:
|
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, Maryland 21205-4010, USA. sikhkim@jhmi.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acrylic Resins
/
therapeutic use Angiography, Digital Subtraction Arteriovenous Anastomosis / radiography* Embolization, Therapeutic / methods* Female Follicle Stimulating Hormone / blood* Gelatin / therapeutic use Humans Leiomyoma / blood, therapy* Middle Aged Ovary / blood supply*, metabolism Premenopause Treatment Outcome Uterine Neoplasms / blood, therapy* Uterus / blood supply*, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Acrylic Resins; 0/trisacryl gelatin microspheres; 9000-70-8/Gelatin; 9002-68-0/Follicle Stimulating Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper pep...
Next Document: Midterm follow-up of a single-center experience of endovascular repair of abdominal aortic aneurysms...